Introduction
Laryngeal leiomyosarcoma (LMS) was first described by Frank in 1941 . 1 These are malignant smooth-muscle tumors originating from cutaneous and subc utaneous tissues, the extremities, genitourinary tract,gastrointestinal tract, and vascular walls.2.3 Overall, the incidence of LMS is less th an 10% of all soft-tissue sarco mas and is usually between 2.3 and 5.3% of malignant soft -tissue tumors in the head and neck region.4.5 Primarysarcomas rare ly occur in th e larynx and account for a mere 0.3 to 1% of all laryngeal malignancies." In one of the largest series of hea d and neck sarcomas, which included 352 patients, Freedman et al reported on ly 4 cases ( 1.1% ) of LMS in the neck region.'
A thorough search of the MEDLINE and EMBASE da tabases revealed only 53 cases of lar yngea l LMS reported to date. Because of the paucity of data, little information exists regarding optimal treatment modalities. The rarity of LMS often leads to a delayed clinic al diagnosis, difficulty in establishing a histologic diagnosis, and confusion regarding its management. In this article we prese nt a rare case of locally advanced LMS of the larynx and discuss this tumor's natural history, management, and the prognosis, as well as extensively reviewing the literatur e.
Case report
The pat ient, a 65-year-old man, presented to the Department of Otorhinolaryngology in February 2005 with complaints of hoarseness of 7 months' duration and breathlessness lasting for 3 months; the latter had progressed to stridor, necessitating an emergency tracheostomy. When the patient was evaluated the next day, endoscopy showed an ulceroproliferative growth involving the bilatera l ary tenoids, false vocal folds, and the laryngeal surface of the epiglottis.
Axial com puted tom ography (CT) showed a heterogeneouslyenhancing soft-tiss ue mass involvingboth th e falseand true vocal folds and extending to the suprag lottis, aryte noi ds, and parag lott ic space ( figure 1 ).
An endoscopic biopsy was performed for tissue diagnosis. Histopathology revealed tumor cells arranged in fascicles and a storiform pattern (figure 2). The cells showed pleomorphism and nuclear atypia,with vesicular to hyperchromatic nuclei.These features were suggestive of LMS of the larynx. Section s were immunostained with the ABC (avidin biotin-peroxidase complex) method, with primary antibod ies directed toward smooth-muscle actin (clone 1A4), desmin (clone D33 ), neuron-specific enolase (NSE;clone H 14),S-l 00protein (polyclonal), and antihuman cytokeratin (clone 5D3 ). Immunohistoc hemistry (IHC) revealed mottled expression of smooth-muscle actin, while desmin, NSE,S-l 00 protein, and cytokeratin were negative. This confir med the diagnosis of LMS.
The pa tien t underwent tot al laryngectomy (TL) with part ial ph aryngectomy and hemithyroidectomy Review of the literature A literature search was done using MEDLINE and EMBASE to identify cases of LMS of the larynx. The search was conducted in all document types, using the following MeSH terms: leiomyosarcoma AND larynx.
The search produced 53 such cases; ours is case number 54. To the extent possible, we extracted data regarding patients' ages/sex, tumor sites, presenting symptoms, therapeutic methods, and outcomes. When full articles were not available, abstracts were used as the source of information. The table includes data derived from 31 of those cases for which abstracts or full articles were available in the English language, as well as the data from our case. The reviewed reports served as a source of information about LMS's clinical behavior, location, treatment, and overall prognosis.
According to Chen et al, the average patient age at presentation is within the fifth decade of life, with a male preponderance.' The average age at presentation of the patients whose data were derived from our literature review, plus our patient, was 58.3 years; 27 of 31 patients (87.1%) were male and only 4 of 31 (12.9%) were female (table). (The age and sex of 1 patient listed in the table are not known.)
The site at which LMSoccurred was not reported for 1 patient whose data were included in the table. LMS was seen in the supraglottis in 5 of the remaining 31 patients (16.1%), while involvement of the glottis was seen in 15 of31 (48.4%) patients; 2 patients had subglottic involvement, and 2 had transglottic involvement (6.5% each). Combined supraglottic-glottic involvement occurred in 4 of31 patients (13.0%), and glottic-subglottic involvement occurred in 3 of31 (9.7%) (table) .
The clinical presentation oflaryngeal LMS is diverse, and its severity depends upon the site, extent, and laterality of the tumor,' Presentation at the time of diagnosis can vary from mild symptoms such as hoarseness to life-threatening symptoms such as stridor. In our review, we found that 19 of31 patients (61.3%) had hoarseness, 11 of 31 (35.5%) had dyspnea/respiratory distress and/ or stridor, 4 of 31 (12.9%) presented with dysphagia, 284' www.entjournal.com (table) . Most of the patients had overlapping symptoms.
Most of the patients whose data we compiled from the literature review (20 of 31 [65.5%]) underwent radical surgery in the form of TL; 10 of 31 (32.3%) had radiotherapy alone or as an adjuvant treatment following TL (table) . Patients with subglottic LMS had a better prognosis.
Discussion
The incidence of LMS varies from 2.3 to 5.3% of malignant soft-issue tumors in the head and neck region.' The rarity of LMS in this region has been attributed to the scarcity ofsmooth muscle in the head and neck. The most common sites ofinvolvement in the head and neck are the paranasal sinuses, scalp, cervical esophagus, and jaws. the origin to aberrant mesenchymal differentiation and have raised the possibility that LMS might be metastatic rather than primary in origin." Histologically,LMS is comprised offascicles ofspind le cells with elongated "cigar shaped;' blunt-ended nuclei. They are distinguished from leiomyomas (benign variant) by their characteristic ma lignant properties (i.e., nuclear mitotic activity, hyperchromatism, and cellular pleornorphism.v'<"
On light microscopy, the tumor shows interlacing bu ndles, or fascicles, ofspindle-shaped cells with multinucleate pleomorphic nuclei. On first inspection this may, as in our case, initially be labeled as a spindle-cell tum or. However, when IH C studies are performed, the differences becom e more apparent. P:'! Specific IHC stains, especia lly desmin, have helped to improve the accuracy of diagnosis and differentiate LMS from other mesodermal tumors, such as fibromas, fibrosarcomas, spindle-cell sarcomas, rhabdomyosarcoma, malignant 286 • www.entjournal. com melanomas, and inflammatory myofibroblastic tumors. v" In most cases, IHC permits a reliable diagnosis ofLMS.
The diag nosis of LMS is also supplemented by the following histopathologic features" :
1. Prese nce of well-oriented , thin myofi laments (60 to 80 A) in a large po rtion ofthe cytoplasm, joined to the membrane by dense bodies; 2. Presence of pinocytic vesicles; and 3. Basal lamina encompassing all of the external membrane.
LMS mimics spindle-cell tumors or other sarcomas in metastasizing by a hematogenous route, mostly to the lung and liver (30 to 50%); regio nal lym phatic involvement tends to be a late phenomenon. The incidence of lymph node metastasis usually does not exceed 10 to 15%.6,1 6
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Surger y rem ains the treatment of choice for LMS. Surgical opt ion s vary according to the site of the lesion and range from conservative procedures,such as microlaryngeal surg ery (MLS),laser debulking, vertica lparti al laryngectomy (VPL), and simple partial laryng ectomy (SPL), to aggressive procedures, such as TL. However, conservative surgeries such as MLS, laser debulking, VPL, and SPL have shown high recurrence rates, and hence are generally not recommended. Neck dissection is not recommended because of the lack of early lymph node metastasis, which has been substantiated by immunohistochemical and ultrastructural studies."
Radiotherapy is primarily used adjuvantly in the postoperative period .The available evidence emphasizes the role of radiotherapy in reducing the risk oflocal recurrences ." Randomized trials for soft-tissue sarcomas of the extremities also have shown that radiotherapy has been effective in controlling local recurrences.P" However, because of the small number of LMS cases, no randomized trials have been designed or pub lished yet to show the effectiveness of adjuvant radiotherapy in head and neck LMS.
The survival statistics for head and neck LMS are inconclusive because of scarcity of data . Data collated from the literature have shown recurrence rates and 5-year survival rates of approximately 30 and 50%, respectively.S,10 From the reviewed literatur-e, it has been observed that subglottic LMStends to have a better prognosis (tab le), while tumors larger than 5 em and deep infiltrative tumors tend to have a poorer prognosis.
